MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Urologic Oncology Seminars and Original Investigations
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

457 results · 1 filter active ·
Results by year
20012025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
457 works in the cohort · of 4,299,418page 9 of 10

Labels cover 2 of 457 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 457 of 457 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Taking the next step—Advancing bladder cancer management
Antonia Vlahou, Peter C. Black, Peter J. Goebell, Ashish M. Kamat, Roman Nawroth, Bernd J. Schmitz‐Dräger
2016· article· en· Urologic Oncology Seminars and Original Investigations· Medicine
machine prediction:candidate · noneconsensus · none
1
citations
affno abstractunlabeled
Corrigendum to ‘Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide’[Urol Oncol: Semin Original Investigat 41(3) (2023) 253.e1-253.e9]
Benjamin Lowentritt, Dominic Pilon, Ibrahim Khilfeh, Carmine Rossi, Erik Muser, Frédéric Kinkead +4 more
2025· erratum· en· Urologic Oncology Seminars and Original Investigations· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Regulation of PPARγ expression in luminal muscle invasive bladder cancer
Davide Tortora, Rebecca Morgan, Gunjan Kumar, Elie Ritch, Brian McConeghy, Sunita Sinha +7 more
2020· article· en· Urologic Oncology Seminars and Original Investigations· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
MICROULTRASOUND IN CANCER – ACTIVE SURVEILLANCE (MUSIC-AS)
Patrick Albers, Betty Wang, Stacey Broomfield, Wendy Tu, Christopher Fung, Adam Kinnaird +1 more
2024· article· en· Urologic Oncology Seminars and Original Investigations· Engineering
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
STIMULATED RAMAN HISTOLOGY AND ARTIFICIAL INTELLIGENCE ALLOWS FOR PREDICTION OF PROSTATE CANCER EXTRAPROSTATIC EXTENSION AND POSITIVE SURGICAL MARGIN DURING RADICAL PROSTECTOMY
Miles P. Mannas, Adrian Ion‐Mărgineanu, Christian W. Freudiger, Lea Lough, James Wysock, William C. Huang +6 more
2025· article· en· Urologic Oncology Seminars and Original Investigations· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About